NASDAQ:KURA

Kura Oncology Stock Predictions

etoro logo Buy KURA
*Your capital is at risk
$8.66
-0.315 (-3.51%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

KURA Prediction Chart

KURA Predictions History

Latest community submissions for KURA.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 23, 2025 $5.94 +1.53% $5.87 V 98.81% 2
Jun 23, 2025 Bearish $5.87 X 0
Mar 12, 2024 $22.33 -2.17% $22.31 V 99.93% 10
Mar 12, 2024 $22.51 -1.35% $22.31 V 99.10% 2
HD HD @HD.102819
Mar 12, 2024 Bullish $22.31 X 0
Jan 18, 2024 $15.03 +1.84% $14.55 X 96.69% 0
Jan 18, 2024 $14.93 +1.15% $14.55 X 97.39% 0
Jan 18, 2024 Bullish $14.55 X 0
JS JS Pro
Mar 11, 2022 $16.58 -1.37% $16.81 X 98.63% 1
Mar 11, 2022 Bearish $16.81 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KURA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KURA ONCOLOGY
Kura Oncology
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, includi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE